These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 14997205)

  • 1. Expression and copy number analysis of TRPS1, EIF3S3 and MYC genes in breast and prostate cancer.
    Savinainen KJ; Linja MJ; Saramäki OR; Tammela TL; Chang GT; Brinkmann AO; Visakorpi T
    Br J Cancer; 2004 Mar; 90(5):1041-6. PubMed ID: 14997205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mapping the amplification of EIF3S3 in breast and prostate cancer.
    Nupponen NN; Isola J; Visakorpi T
    Genes Chromosomes Cancer; 2000 Jun; 28(2):203-10. PubMed ID: 10825005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amplification and overexpression of p40 subunit of eukaryotic translation initiation factor 3 in breast and prostate cancer.
    Nupponen NN; Porkka K; Kakkola L; Tanner M; Persson K; Borg A; Isola J; Visakorpi T
    Am J Pathol; 1999 Jun; 154(6):1777-83. PubMed ID: 10362802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PTK2 and EIF3S3 genes may be amplification targets at 8q23-q24 and are associated with large hepatocellular carcinomas.
    Okamoto H; Yasui K; Zhao C; Arii S; Inazawa J
    Hepatology; 2003 Nov; 38(5):1242-9. PubMed ID: 14578863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amplification of EIF3S3 gene is associated with advanced stage in prostate cancer.
    Saramäki O; Willi N; Bratt O; Gasser TC; Koivisto P; Nupponen NN; Bubendorf L; Visakorpi T
    Am J Pathol; 2001 Dec; 159(6):2089-94. PubMed ID: 11733359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression and gene amplification of BAG-1L in hormone-refractory prostate cancer.
    Mäki HE; Saramäki OR; Shatkina L; Martikainen PM; Tammela TL; van Weerden WM; Vessella RL; Cato AC; Visakorpi T
    J Pathol; 2007 Aug; 212(4):395-401. PubMed ID: 17503439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RAD21 and KIAA0196 at 8q24 are amplified and overexpressed in prostate cancer.
    Porkka KP; Tammela TL; Vessella RL; Visakorpi T
    Genes Chromosomes Cancer; 2004 Jan; 39(1):1-10. PubMed ID: 14603436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression and gene copy number analysis of ERBB2 oncogene in prostate cancer.
    Savinainen KJ; Saramäki OR; Linja MJ; Bratt O; Tammela TL; Isola JJ; Visakorpi T
    Am J Pathol; 2002 Jan; 160(1):339-45. PubMed ID: 11786427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amplification and overexpression of androgen receptor gene in hormone-refractory prostate cancer.
    Linja MJ; Savinainen KJ; Saramäki OR; Tammela TL; Vessella RL; Visakorpi T
    Cancer Res; 2001 May; 61(9):3550-5. PubMed ID: 11325816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The gene for polycomb group protein enhancer of zeste homolog 2 (EZH2) is amplified in late-stage prostate cancer.
    Saramäki OR; Tammela TL; Martikainen PM; Vessella RL; Visakorpi T
    Genes Chromosomes Cancer; 2006 Jul; 45(7):639-45. PubMed ID: 16575874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Scanning copy number and gene expression on the 18q21-qter chromosomal region by the systematic multiplex PCR and reverse transcription-PCR methods.
    Yamamoto F; Yamamoto M
    Electrophoresis; 2007 Jun; 28(12):1882-95. PubMed ID: 17523142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The TRPS1 transcription factor: androgenic regulation in prostate cancer and high expression in breast cancer.
    Chang GT; Jhamai M; van Weerden WM; Jenster G; Brinkmann AO
    Endocr Relat Cancer; 2004 Dec; 11(4):815-22. PubMed ID: 15613454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of ERalpha and ERbeta in prostate cancer.
    Linja MJ; Savinainen KJ; Tammela TL; Isola JJ; Visakorpi T
    Prostate; 2003 May; 55(3):180-6. PubMed ID: 12692783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased dosage and amplification of the focal adhesion kinase gene in human cancer cells.
    Agochiya M; Brunton VG; Owens DW; Parkinson EK; Paraskeva C; Keith WN; Frame MC
    Oncogene; 1999 Oct; 18(41):5646-53. PubMed ID: 10523844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic profiling of chromosome 1 in breast cancer: mapping of regions of gains and losses and identification of candidate genes on 1q.
    Orsetti B; Nugoli M; Cervera N; Lasorsa L; Chuchana P; Rougé C; Ursule L; Nguyen C; Bibeau F; Rodriguez C; Theillet C
    Br J Cancer; 2006 Nov; 95(10):1439-47. PubMed ID: 17060936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of EIF3S3 promotes cancer cell growth.
    Savinainen KJ; Helenius MA; Lehtonen HJ; Visakorpi T
    Prostate; 2006 Aug; 66(11):1144-50. PubMed ID: 16652384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-level TOP2A amplification in prostate cancer is associated with HER2 duplication, androgen resistance, and decreased survival.
    Murphy AJ; Hughes CA; Barrett C; Magee H; Loftus B; O'Leary JJ; Sheils O
    Cancer Res; 2007 Mar; 67(6):2893-8. PubMed ID: 17363613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A widely expressed transcription factor with multiple DNA sequence specificity, CTCF, is localized at chromosome segment 16q22.1 within one of the smallest regions of overlap for common deletions in breast and prostate cancers.
    Filippova GN; Lindblom A; Meincke LJ; Klenova EM; Neiman PE; Collins SJ; Doggett NA; Lobanenkov VV
    Genes Chromosomes Cancer; 1998 May; 22(1):26-36. PubMed ID: 9591631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coamplification of prostate stem cell antigen (PSCA) and MYC in locally advanced prostate cancer.
    Reiter RE; Sato I; Thomas G; Qian J; Gu Z; Watabe T; Loda M; Jenkins RB
    Genes Chromosomes Cancer; 2000 Jan; 27(1):95-103. PubMed ID: 10564591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amplification and overexpression of vinculin are associated with increased tumour cell proliferation and progression in advanced prostate cancer.
    Ruiz C; Holz DR; Oeggerli M; Schneider S; Gonzales IM; Kiefer JM; Zellweger T; Bachmann A; Koivisto PA; Helin HJ; Mousses S; Barrett MT; Azorsa DO; Bubendorf L
    J Pathol; 2011 Mar; 223(4):543-52. PubMed ID: 21294127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.